Technical Analysis for NARI - Inari Medical, Inc.

Grade Last Price % Change Price Change
A 107.07 1.45% 1.53
NARI closed up 1.45 percent on Friday, January 22, 2021, on 59 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical NARI trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Doji - Bearish? Reversal 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Older End-of-Day Signals for NARI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% about 16 hours ago
Rose Above Previous Day's High about 18 hours ago
New 52 Week High about 18 hours ago
Up 1% about 18 hours ago
60 Minute Opening Range Breakout about 19 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inari Medical, Inc. Description

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease Catheter Hematology FDA Quality Of Life Vein Thrombosis Angiology Blood Clots Deep Vein Thrombosis Embolectomy Pulmonary Embolism Thrombectomy Thrombus Venous Diseases

Is NARI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 108.11
52 Week Low 39.55
Average Volume 752,430
200-Day Moving Average 0.00
50-Day Moving Average 77.17
20-Day Moving Average 89.11
10-Day Moving Average 95.33
Average True Range 4.90
ADX 39.98
+DI 40.94
-DI 7.73
Chandelier Exit (Long, 3 ATRs ) 93.41
Chandelier Exit (Short, 3 ATRs ) 83.91
Upper Bollinger Band 106.58
Lower Bollinger Band 71.65
Percent B (%b) 1.01
BandWidth 39.20
MACD Line 7.85
MACD Signal Line 5.95
MACD Histogram 1.8961
Fundamentals Value
Market Cap 5.22 Billion
Num Shares 48.7 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -862.08
Price-to-Sales 28.37
Price-to-Book 16.46
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 114.53
Resistance 3 (R3) 114.04 111.08 113.28
Resistance 2 (R2) 111.08 109.18 111.32 112.87
Resistance 1 (R1) 109.07 108.01 110.08 109.56 112.45
Pivot Point 106.11 106.11 106.61 106.35 106.11
Support 1 (S1) 104.10 104.21 105.11 104.59 101.69
Support 2 (S2) 101.14 103.04 101.38 101.27
Support 3 (S3) 99.13 101.14 100.86
Support 4 (S4) 99.62